Skip to content
★ Sign in to follow
Total declarations
2
Company
1
▲ Purchases (0 ops.)
—
▼ Sales (0 ops.)
—

Latest filing published 10 Aug 2026 for TAKEDA PHARMACEUTICAL CO LTD, €308k.

Insider track record

Disclosed buys
0
Disclosed sells
0
Signal history

No signal scores available.

Elaine Shannon: trading record in brief

All filings by Elaine Shannon on record concern Takeda Pharmaceutical Co Ltd. Between 13 July 2026 and 10 August 2026, the trades on record add up to 2 filings.

The filings describe grants, exercises and other transfers rather than trades on the open market. Grants and option exercises follow pay plans set in advance, so they reveal less about an insider's own view than a purchase made with personal money.

Most recently, on 10 August 2026, the filings show a transaction worth €308k in Takeda Pharmaceutical Co Ltd. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.

Companies and markets linked to Elaine Shannon

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations2 total
  • ●
    President, Global Supply & QualityExecutives(filed)Takeda Pharmaceutical Co Ltd
    355,334 USD0Source
    20,363 shares@ US$17.45American Depositary Shares (ADSs)SEC144:0001493152-26-036878
  • ●
    President, Global Supply & QualityExecutivesTakeda Pharmaceutical Co Ltd
    72,351 USD33Source
    4,319 shares@ US$16.75190.0001% mcap100.0% of flowAmerican Depositary Shares (ADSs)SEC144:0001395064-26-000311

2 of 2 declarations